Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IVACAFTOR for Chronic obstructive pulmonary disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where IVACAFTOR was used for Chronic obstructive pulmonary disease.

Most Reported Side Effects for IVACAFTOR

Side Effect Reports % Deaths Hosp.
Hospitalisation 1,209 18.0% 17 1,202
Infective pulmonary exacerbation of cystic fibrosis 550 8.2% 20 445
Infection 227 3.4% 3 122
Malaise 226 3.4% 5 137
Lower respiratory tract infection 224 3.3% 2 212
Pneumonia 215 3.2% 10 184
Death 203 3.0% 203 32
Cough 180 2.7% 0 56
Cystic fibrosis 167 2.5% 10 148
Headache 163 2.4% 0 38
Nasopharyngitis 151 2.2% 2 42
Influenza 149 2.2% 0 87
Pulmonary function test decreased 121 1.8% 1 89
Dyspnoea 108 1.6% 4 62
Abdominal pain upper 102 1.5% 0 27

Other Indications for IVACAFTOR

Cystic fibrosis (6,594) Product used for unknown indication (24)

Other Drugs Used for Chronic obstructive pulmonary disease

TIOTROPIUM (20,175) FLUTICASONE\SALMETEROL (8,896) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (8,730) ALBUTEROL (8,572) BUDESONIDE\FORMOTEROL (6,539) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (4,580) UMECLIDINIUM\VILANTEROL TRIFENATATE (4,512) DUPILUMAB (3,526) ALBUTEROL\IPRATROPIUM (3,289) ACLIDINIUM (2,321)

Related Pages

IVACAFTOR Full Profile All Chronic obstructive pulmonary disease Drugs IVACAFTOR Demographics IVACAFTOR Timeline